The BioEscalator, Oxford University's Biotech incubator, provides lab space and entrepreneurial support for high growth startups.
Oxford’s Old Road Campus is home to many of the University’s world-class institutes and departments, with 8500 staff and students tackling the full range of medical health challenges across the world. The BioEscalator builds on this success by nurturing early-stage biotech companies through to sustainability, by facilitating collaboration with NHS and academics, to build a community of entrepreneurial medical scientists and innovators.
Our focus is on getting more discoveries out of the lab and into patient care by providing fully equipped shared facilities allowing your company to start innovating from the moment you move in.
22 October 2021
Recipients of the OBN Awards are considered to have made an outstanding and valuable contribution to their field, which is why Ochre Bio is thrilled to have made the cut at this early stage of its life.
13 October 2021
PepGen, Inc., a company advancing next-generation oligonucleotide therapies for neuromuscular and neurologic diseases, today announced the appointment of neuromuscular neurologist John W. Day, M.D., PhD, to its Scientific Advisory Board. Dr Day is a Professor of Neurology, Pediatrics (Genetics) and Pathology and Director of the Division of Neuromuscular Medicine at Stanford University.
1 September 2021
The BioEscalator concept was born out of a shared need by academic researchers and their bioscience company collaborators for start-up incubator space close to academic labs. The vision was to develop a leading international centre for innovative bioscience with the potential to make a significant impact on healthcare. The incubator provides spin-outs and start-ups with laboratory and business support, enabling them to grow into leading bioscience ventures.
Thursday, 01 July 2021 to Thursday, 10 February 2022
On 1st of July 2021, 4th of November 2021 and 10th of February 2022 from 3-6.30pm, up to six early-stage companies having a direct or indirect impact on patients will be presenting their business and products.
Wednesday, 08 December 2021
Fostering UK innovation and patient access to cutting-edge medicines.
Thursday, 09 December 2021
Genesis is approaching its 21st Birthday – and you’re invited to the party! Genesis 2021 will assemble senior executives and decision-makers from across the Life Science, Healthcare and Technology field to present, discuss and demonstrate their collective insight and thought leadership for the sector.
OBN Christmas Lecture 2021 - How will the AlphaFold 2 Protein Database Revolutionise Drug Discovery?
Tuesday, 14 December 2021, 6pm to 9pm
Dame Janet Thornton, Director Emeritus of EMBL-EBI is OBN's special guest presenter of the OBN Christmas Lecture for 2021, who will share her insight into the ground-breaking impact of the AlphaFold 2 Protein database and the importance of open science.
Old Road Campus